Back to all Resources

Infographics
September 5, 2023

Diabetes Infographic: Real-time Patient Insights from Medisafe

Highlights from the Diabetes Infographic

  • The frequency of dosing schedules in both the GLP-1 class and Insulin impacts the rate of adherence
  • 71% of Medisafe users improved their adherence after adding a Medisafe Medfriend who is alerted each time a dose is missed
  • 17% improvement of average reported adherence rate a after adding a Medifriend

What insights can we discover about your brand? Contact us to find out!

Full Diabetes Adherence Insights

Reported Diabetes Drug Adherence by Drug & Dose

  • GLP-1, 1x/week: 88%
  • GLP-1, 1x/day: 80%
  • GLP-1, 2x/day: 77%
  • Insulin, Long-acting 1-2x/day: 79%
  • Insulin, Intermediate-acting 1-2x/day: 78%
  • Insulin, Short-acting 2-3x/day: 73%
  • Insulin, Rapid-acting 3x/day: 73%

Injectables versus Orals

  • All GLP-1 and insulin injectables: 76%
  • All oral diabetic meds: 74%

What insights can we discover about your brand? Contact us to find out!

Back to all Resources

Article
Dec 10, 2025
Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs

Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 breast cancer–related deaths projected in the United States in 2025 (American Cancer Society, 2025). Despite advances in targeted oral therapies for extended adjuvant treatment, real‐world studies find that up to 50% of patients discontinue or skip doses, undermining efficacy (Mayo Clinic, 2024).

Watch Webinar

Article
Oct 22, 2025
Pharmaceutical Companies Can Now Use AI to Streamline the Patient Experience with Medisafe and Infinitus

Leading pharmaceutical companies are now using AI to help healthcare providers simplify and streamline the patient experience for specialty medications, which can be difficult to access, adhere to, and afford.

Watch Webinar

Article
Dec 22, 2025
Medisafe Empowers Pharma: Elevating Cardiovascular Drug Launches

Medisafe has pioneered an ecosystem of digital solutions aimed at addressing critical Pharma challenges. The Medisafe Digital Companion stands out as a comprehensive tool that provides personalized medication management, reminders, and educational content. Research indicates that Medisafe users exhibit improved medication adherence rates, with some studies showing an adherence rate increase of over 20%.

Watch Webinar

Build a smarter patient engagement strategy

See how Medisafe helps pharmaceutical teams activate patients, improve adherence, and measure outcomes across their portfolio.

Request a Demo
Platform
For PharmaFor ProvidersFor PatientsDownload App
Therapeutic Areas
CardiovascularInflammatoryMental HealthMetabolic / GLP-1NeurologyOncology
Resources
ResearchArticlesInfographicsMediscoveries
Company
About MedisafeCareersNews & EventsContact

© 2026 Medisafe. All rights reserved.

Privacy PolicyTerms & ConditionsConsumer Health Data Policy